US2004115624A1PendingUtilityA1
Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
Priority: Oct 11, 2001Filed: Nov 17, 2003Published: Jun 17, 2004
Est. expiryOct 11, 2021(expired)· nominal 20-yr term from priority
Inventors:Wondu Wolde-Mariam
G01N 33/54388G01N 2333/315Y10S436/81G01N 2333/34G01N 2333/355G01N 2333/31G01N 33/56911G01N 2469/10Y10S435/973G01N 2333/35Y10S435/97Y10S436/823G01N 2333/245G01N 2333/30G01N 2333/39
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention involves a method and an immuno-analytical device for the rapid and simultaneous detection of multiple micro-organisms in the biological fluids from milk-producing animals suffering from mastitis. This method is based on a lateral flow immuno-assay technique performed to detect antigens specific for multiple infectious agents which are known to cause and/or be encountered in cases of mastitis. Mastitis is an inflammatory condition affecting the udders of milk-producing animals as a result of microbial infections.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for detecting a plurality of different pathogens in a milk sample of a mammal, comprising:
exposing said milk sample to a plurality of different antibodies specific to an antigen from a pathogen of said mammal; and identifying whether said specific antibodies bind to one or more of said antigens, wherein said antigens are from a plurality of different pathogens.
2 . The method of claim 1 wherein the milk sample is allowed to settle into two phases before exposing and wherein the top “clear” phase is exposed.
3 . The method of claim 1 wherein the milk sample is diluted before exposing.
4 . The method of claim 1 wherein the cream is removed from the top of the milk before exposing.
5 . The method of claim 1 wherein said milk sample is treated to remove at least about 50% of the fat and/or the casein.
6 . The method of claim 5 wherein said treatment comprises adding a detergent to remove the fat globules and precipitating the casein with acid.
7 . The method of claim 1 wherein said antibodies are specific for a pathogen selected from the group consisting of a bacteria, a virus, and a fungus.
8 . The method of claim 1 wherein said milk-producing animal is a cow, a sheep or a goat.
9 . The method of claim 7 wherein said pathogen is a bacteria selected from the group consisting of: Streptococcus spp., Enterococcus spp., Staphylococcus spp., Micrococcus spp., Escherischia coli , Klebsiella spp. Enterobacteria, Serratia spp., Pseudomonas spp., Proteus spp., Pasteurella spp., Corynebacterium bovis, Arcanobacterium pyogenes , Mycobacterium spp., Bacillus spp., and Mycoplasma spp.
10 . The method of claim 7 wherein said pathogen is a yeast or a mold selected from the group consisting of: Nocardia spp. and Prototheca.
11 . The method of claim wherein said pathogen is selected from the group consisting of: S. agalactiae, S. dysgalactiae , and S. uberis.
12 . The method of claim 7 wherein said pathogen is Staphylococcus aureus.
13 . The method of claim 7 wherein said pathogen is a. coagulase-negative Staphylococcus.
14 . The method of claim 7 wherein said mycoplasma is selected from the group consisting of M. bovis, M. californicum , and M. bovigenitaliae.
15 . The method of claim 1 wherein said antibodies are specific to antigens from at least 3 different pathogens.
16 . The method of claim 1 wherein said antibodies are specific to 7 pathogens.
17 . The method of claim 1 wherein said antibodies are specific to 10 pathogens.
18 . The method of claim 15 wherein said 3 pathogens are Streptococcus agalactiae, Staphylococcus aureus , and Mycoplasma bovis.
19 . The method of claim 16 wherein said 7 pathogens are Streptococcus agalactiae, Staphylococcus aureus, Mycoplasma bovis, Escherichia coli , coagulase-negative Staphylococci, M. californicum , and M. bovigenitaliae.
20 . The method of claim 1 wherein said pathogens are selected from the group consisting Staphylococcus aureus , non-hemolytic Staphylococci, Mycoplasma capricolu, M. mycoides subspecies mycoides, M. putrefaciens, Mycoplasma agalactiae, M. arginini, M. conjunctivae, M. ovipnuemoniae , and Mycoplasma strain F38.
21 . The method of claim 1 further comprising a lateral flow test format.
22 . The method of claim 1 , further comprising:
immobilizing said antibodies on one or more test membranes; and identifying the presence of the pathogen using a second antibody which is free to move by capillary action within the membrane.
23 . The method of claim 22 , wherein said second antibody is conjugated to a marker.
24 . The method of claim 23 , wherein said marker is a color-producing agent.
25 . The method of claim 24 , wherein said color-producing agent is colloidal gold or a colored latex micro-sphere.
26 . The method of claim 22 , wherein said more than one test membrane is arranged longitudinally side by side.
27 . The method of claim 22 , wherein said method allows concurrent visualization of test results.
28 . The method of claim 1 , wherein said antibodies are polyclonal, monoclonal, or parts thereof.
29 . A kit for the detection of a plurality of pathogens in milk, comprising:
a plurality of antibodies, wherein said antibodies are specific to an antigen from a pathogen of milk, wherein said antigens are from a plurality of pathogens; and a marker for the binding of said antibodies to said antigen.
30 . The kit of claim 29 , further comprising a container which allows the milk to be collected.
31 . The kit of claim 29 , further comprising cleaning products for the removal of organisms from the outside of a milk-producing organ.
32 . The kit of claim 29 , further comprising at least one antibody specific to antigens from granulocytes.
33 . The kit of claim 32 wherein said granulocytes are neutrophils.
34 . The method of claim 1 , further comprising identifying the presence of ganulocytes as a general indicator of mastitis.
35 . The method of claim 34 , wherein said identifying comprises exposing said milk sample to at least one antibody specific to antigens from neutrophils.Join the waitlist — get patent alerts
Track US2004115624A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.